310 related articles for article (PubMed ID: 19660554)
1. Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study.
Matsumoto R; Ichise M; Ito H; Ando T; Takahashi H; Ikoma Y; Kosaka J; Arakawa R; Fujimura Y; Ota M; Takano A; Fukui K; Nakayama K; Suhara T
Neuroimage; 2010 Jan; 49(1):121-6. PubMed ID: 19660554
[TBL] [Abstract][Full Text] [Related]
2. Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity - a [11C]DASB PET study.
Reimold M; Smolka MN; Zimmer A; Batra A; Knobel A; Solbach C; Mundt A; Smoltczyk HU; Goldman D; Mann K; Reischl G; Machulla HJ; Bares R; Heinz A
J Neural Transm (Vienna); 2007; 114(12):1603-9. PubMed ID: 17713719
[TBL] [Abstract][Full Text] [Related]
3. Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907.
Simpson HB; Slifstein M; Bender J; Xu X; Hackett E; Maher MJ; Abi-Dargham A
Biol Psychiatry; 2011 Nov; 70(9):897-904. PubMed ID: 21855857
[TBL] [Abstract][Full Text] [Related]
4. PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method.
Kim JS; Ichise M; Sangare J; Innis RB
J Nucl Med; 2006 Feb; 47(2):208-14. PubMed ID: 16455625
[TBL] [Abstract][Full Text] [Related]
5. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.
Cannon DM; Ichise M; Rollis D; Klaver JM; Gandhi SK; Charney DS; Manji HK; Drevets WC
Biol Psychiatry; 2007 Oct; 62(8):870-7. PubMed ID: 17678634
[TBL] [Abstract][Full Text] [Related]
6. Higher serotonin transporter availability in early-onset obsessive-compulsive disorder patients undergoing escitalopram treatment: A [
Lee J; Kim BH; Kim E; Howes OD; Cho KIK; Yoon YB; Kwon JS
Hum Psychopharmacol; 2018 Jan; 33(1):. PubMed ID: 29210107
[TBL] [Abstract][Full Text] [Related]
7. The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder.
Hesse S; Stengler K; Regenthal R; Patt M; Becker GA; Franke A; Knüpfer H; Meyer PM; Luthardt J; Jahn I; Lobsien D; Heinke W; Brust P; Hegerl U; Sabri O
Int J Neuropsychopharmacol; 2011 Jun; 14(5):606-17. PubMed ID: 21232166
[TBL] [Abstract][Full Text] [Related]
8. Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study.
Kim E; Howes OD; Park JW; Kim SN; Shin SA; Kim BH; Turkheimer FE; Lee YS; Kwon JS
Psychol Med; 2016 Jan; 46(2):357-66. PubMed ID: 26423910
[TBL] [Abstract][Full Text] [Related]
9. [123I]-beta-CIT SPECT imaging shows reduced thalamus-hypothalamus serotonin transporter availability in 24 drug-free obsessive-compulsive checkers.
Zitterl W; Aigner M; Stompe T; Zitterl-Eglseer K; Gutierrez-Lobos K; Schmidl-Mohl B; Wenzel T; Demal U; Zettinig G; Hornik K; Thau K
Neuropsychopharmacology; 2007 Aug; 32(8):1661-8. PubMed ID: 17192774
[TBL] [Abstract][Full Text] [Related]
10. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography.
Cannon DM; Ichise M; Fromm SJ; Nugent AC; Rollis D; Gandhi SK; Klaver JM; Charney DS; Manji HK; Drevets WC
Biol Psychiatry; 2006 Aug; 60(3):207-17. PubMed ID: 16875929
[TBL] [Abstract][Full Text] [Related]
11. Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [(11)C]McN 5652.
Simpson HB; Lombardo I; Slifstein M; Huang HY; Hwang DR; Abi-Dargham A; Liebowitz MR; Laruelle M
Biol Psychiatry; 2003 Dec; 54(12):1414-21. PubMed ID: 14675806
[TBL] [Abstract][Full Text] [Related]
12. Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder.
Zitterl W; Aigner M; Stompe T; Zitterl-Eglseer K; Gutierrez-Lobos K; Wenzel T; Zettinig G; Hornik K; Pirker W; Thau K
Neuropsychopharmacology; 2008 Dec; 33(13):3126-34. PubMed ID: 18354388
[TBL] [Abstract][Full Text] [Related]
13. Altered brain serotonin transporter and associated glucose metabolism in Alzheimer disease.
Ouchi Y; Yoshikawa E; Futatsubashi M; Yagi S; Ueki T; Nakamura K
J Nucl Med; 2009 Aug; 50(8):1260-6. PubMed ID: 19617327
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D1 receptor binding in the striatum of patients with obsessive-compulsive disorder.
Olver JS; O'Keefe G; Jones GR; Burrows GD; Tochon-Danguy HJ; Ackermann U; Scott A; Norman TR
J Affect Disord; 2009 Apr; 114(1-3):321-6. PubMed ID: 18706700
[TBL] [Abstract][Full Text] [Related]
15. Dopamine transporter density of basal ganglia assessed with [123I]IPT SPET in obsessive-compulsive disorder.
Kim CH; Koo MS; Cheon KA; Ryu YH; Lee JD; Lee HS
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1637-43. PubMed ID: 14513291
[TBL] [Abstract][Full Text] [Related]
16. Reduced midbrain-pons serotonin transporter binding in patients with obsessive-compulsive disorder.
Hasselbalch SG; Hansen ES; Jakobsen TB; Pinborg LH; Lønborg JH; Bolwig TG
Acta Psychiatr Scand; 2007 May; 115(5):388-94. PubMed ID: 17430417
[TBL] [Abstract][Full Text] [Related]
17. Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV.
Hammoud DA; Endres CJ; Hammond E; Uzuner O; Brown A; Nath A; Kaplin AI; Pomper MG
Neuroimage; 2010 Feb; 49(3):2588-95. PubMed ID: 19853044
[TBL] [Abstract][Full Text] [Related]
18. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.
Meyer JH; Houle S; Sagrati S; Carella A; Hussey DF; Ginovart N; Goulding V; Kennedy J; Wilson AA
Arch Gen Psychiatry; 2004 Dec; 61(12):1271-9. PubMed ID: 15583118
[TBL] [Abstract][Full Text] [Related]
19. The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study.
Hansen ES; Hasselbalch S; Law I; Bolwig TG
Int J Neuropsychopharmacol; 2002 Mar; 5(1):1-10. PubMed ID: 12057027
[TBL] [Abstract][Full Text] [Related]
20. Serotonin transporter availability in impulsive aggressive personality disordered patients: a PET study with [11C]DASB.
van de Giessen E; Rosell DR; Thompson JL; Xu X; Girgis RR; Ehrlich Y; Slifstein M; Abi-Dargham A; Siever LJ
J Psychiatr Res; 2014 Nov; 58():147-54. PubMed ID: 25145808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
